'We have to deal with uncertainty': FDA leaders explain how Covid-19 has upended cancer research and care - STAT

'We have to deal with uncertainty': FDA leaders explain how Covid-19 has upended cancer research and care - STAT

STAT Plus: ‘We have to deal with uncertainty’: FDA leaders explain how Covid-19 has upended cancer research and care

By ALEXANDER SPINELLI

JACQUELYN MARTIN/AP

The Covid-19 pandemic has wreaked havoc across the globe — including upending the process of drug development in clinical trials for oncology.

READ MORE